Increasing cases of allergic rhinitis and infections and rising level of pollution are anticipated to propel the growth of the global nasal spray market. The global nasal spray market is expected to grow in the forecast period of 2018 to 2025 with the CAGR of 7.0%.
According to Data Bridge Market Research new Market report, “By Product Type (Decongestion Nasal Spray, Salt Water Solution/ Saline Nasal Spray, Steroid Nasal Spray), By Container Design (Pressurized Canisters, Pump Bottles), By Dosage form (Unit/Single dose, Bi-Dose, Multi-Dose), By Prescription (Prescribed, Over-The-Counter), By Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), By Application (Allergic, Non-Allergic Rhinitis, Nasal Congestion, CNS Disorders, Vaccination, Others), By End-User (Hospitals, Clinics, Home Care Settings, Pharmacies, Community Health Care), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 21.87 billion by 2025, at a CAGR of 7.0% during the forecast period of 2018 to 2025.
Click Here For Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-nasal-spray-market
Global Nasal Spray Market
Nasal sprays are used for the treatment of nasal congestion and infections. They are also used effectively in the treatment of paranasal sinuses such as allergic & non-allergic sinusitis & rhinitis. To solve the problem of degradation of the drug before reaching the target site, to solve the problem of slow absorption and poor bioavailability the nasal drug delivery technique is used. The key players are focusing on growth strategies such as geographical expansion and acquisitions, new product launch, R&D development for the growth of the market. For instance, In October 2016, Adapt Pharma received Health Canada approval for its naloxone hydrochloride nasal spray, which is used for the treatment of opioid overdose.
According to asthma allergy foundation of America, allergic rhinitis affects 6.1 million of the children population and 20 million of the adult population in United States.
According to statista, in 2015, the second leading nasal spray brand of the United States was Afrin, which amounted the sales of approximately 55.9 million USD.
To Avail 10% Discount On This Report Mail Us on: – email@example.com
Global Nasal Spray Market– Segmentation:
The global market for nasal spray by the following sub-categories is presented
v By Product Type
- Decongestion Nasal Spray
- Salt Water Solution/
- Steroid Nasal Spray
v By Container Design
- Pressurized Canisters
- Pump Bottles
v By Dosage Form
- Unit/Single dose
v By Prescription
v By Therapeutic Class
- Nasal Steroids
- Mast Cell Inhibitor
v By Application
- Non-Allergic Rhinitis
- Nasal Congestion
- CNS Disorders
v By End-User
- Home Care Settings
- Community Health Care
v By Geography
- North America
- South America
- Middle East and Africa
For More Details In-Depth Inquiry @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nasal-spray-market
FACTORS DRIVING GROWTH IN THE GLOBAL NASAL SPRAY MARKET
Increasing cases of allergic rhinitis and infections:
It is found that allergic rhinitis affects 10 to 30% of children and adults in the U.S. and other countries. Prevalence of allergic rhinitis is countries such as Australia, New Zealand and the United Kingdom is more. According to National Center for Biotechnology Information 2016, In India more than 20-30% of the population was affected with an allergic rhinitis. This allergic disorder is increasing rapidly from past two decades. It was found that every 1 out of 2 individual is affected by it.
Allergic rhinitis is a global health problem also with economic & societal burdens. About 40.0 % of the world’s population is suffering from this condition. The reported incidence of the allergic rhinitis in western countries is 1.4%-39.7%.
Hence, with the increasing incidences of the nasal infection, respiratory diseases, allergic rhinitis, paranasal sinuses globally, the nasal spray market is expected to achieve the inclining growth due to certain advantages such as self-administration, improvement in patient compliance and painless drug delivery.
Rising level of pollution:
According to a research article published by the Atlanta healthcare, it has been observed that breathing in polluted air could increase the risk of sinus problems. The quality of air in your city can make the difference in your breathing and health issues. The main reason behind asthma, breathing problem, heart and lung diseases, sinus pain, sinus headache, allergy and chronic sinus problems is increasing air pollution. There are various pollutants present in air such as carbon monoxide, nitrogen oxide, sulphur dioxide, which cause air pollution. Many researchers have found that increase in air pollution also increases the risk of chronic sinusitis.
According to the study published in the American Journal of Respiratory Cell and Molecular Biology, researchers have found that there is breakdown in the integrity of nasal air passage and sinus due to the intake of polluted air. Hence, people living in Delhi, which is the highest polluted city in India, are more exposed to chronic sinus problems. The world health organization, in 2016, said that 92% of the world’s population lives in places where air quality levels are beyond WHO safety limits. They also claimed that around three million deaths a year are due to exposure to outdoor air pollution.
With the increase in development of industries, automotive sector, construction, deforestation the pollution is increasing every year, which is creating various respiratory issues, as well as allergic disorders, sinus problems. All these factors are creating opportunities for the growth of the market.
Some of the major market players in this market are Cipla Inc., Maya Biotech, Aurena, Premier Filling Company, Inc, Sandoz International GmbH, Catalent, Inc, Pfizer Inc, AptarGroup, Inc, ADAPT Pharma, Inc, Mylan N.V, INNOVUS PHARMACEUTICALS, INC, Valeant., ALLERGAN, Nephron Pharmaceuticals Corporation, Meda pharmaceuticals, Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, Apotex Inc., Novartis AG among others.
Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-nasal-spray-market
Table of Contents:
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. NASAL SPRAY MARKET, BY PRODUCT TYPE
6. NASAL SPRAY MARKET, BY CONTAINER DESIGN
7. NASAL SPRAY MARKET, BY DOSAGE FORM
8. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY
9. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
10. NASAL SPRAY MARKET, BY APPLICATION
11. NASAL SPRAY MARKET, BY END USER
12. NASAL SPRAY MARKET, BY GEOGRAPHY
13. NASAL SPRAY MARKET: COMPETITIVE LANDSCAPE
14. NASAL SPRAY MARKET, COMPANY PROFILE
View Full Report @ https://databridgemarketresearch.com/reports/global-nasal-spray-market/
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing firstname.lastname@example.org . We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar